• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Analysis-Europe’s record IPO year has a sting in its tail

October 8, 2021 by David Barret Leave a Comment

October 8, 2021

By Abhinav Ramnarayan and Oliver Hirt

LONDON (Reuters) – Europe’s record year for initial public offerings (IPOs) is threatening to come to a juddering halt as inflation fears and concerns over a property crisis in China have soured investors’ appetite for new stock listings.

Deal cancellations and postponements have started to hit the screens with France’s Icade Sante and Switzerland’s Chronext pulling deals in the past week.

Czech company Eurowag pushed through a reduced-size London IPO on Friday, but the trucking services group’s stock fell 10% from its 150 pence offer price.

Many companies that listed earlier in the year are trading below their IPO price, with the FTSE Renaissance IPO Index for the Europe, Middle East and Africa region down 9.19% so far this year.

“Fear of inflation and rising interest rates, as well as uncertainty around China, have made many investors more cautious,” said Christoph Lang, head of core equities in Europe for J. Safra Sarasin. “The Goldilocks environment we had for the last twelve months is over.”

The United States has also been hit by the shift in investors’ mood, with Peleton rival iFIT dropping its IPO plans, while shares in fitness centre operator Life Time’s opened 8% below their offer price on its debut.,

This contrasts with the first nine months of 2021, when listings surged to their the highest level since the dotcom bubble of 2000, based on Refinitiv data, even if the pace slowed in the third quarter.

The IPO market closely reflects investors’ appetite for risk and they tend to become more reluctant to commit large chunks of cash to a single company if the broader economic environment is showing signs of strain.

Uncertainty over the fate of heavily indebted Chinese property company Evergrande and rising bond yields on the back of strong inflation numbers have hit stock markets globally. The MSCI’s World Index is down over 4% over the past month.

“We’ve had something of a buyers’ strike, which is not a phrase I’ve had to use for a while,” said one senior banker who manages IPOs in Europe, preferring to remain anonymous as he is not authorised to speak about his clients.

“The market has turned quite viciously and investors are reluctant to put money to work in IPOs unless they are a complete slam dunk.”

He said that apart from the deal cancellations, a number of IPOs that were being prepared behind the scenes are being postponed.

A few high-profile IPOs are still heading for market, led by Volvo Cars in Sweden, a company that is hoping to tap into the huge appetite for electric vehicle makers and deliver what would be the biggest stock market listing in Europe in 2021.

Bankers also said the Nordic market feels slightly insulated from the travails elsewhere.

Swedish spam blocking app Truecaller completed an IPO that valued it at SEK 19.43 billion ($2.21 billion) and traded up from its list price on Friday.

Norwegian robotics company Autostore is planning an Oslo listing this month that could value it at up to NOK 103.4 billion ($12.04 billion).

Others braving the market turbulence include French cloud computing company OVHCloud, which is due to price its IPO next week, and Russian software group Softline, which is planning a London IPO in the coming weeks.

($1 = 8.7945 Swedish crowns)

($1 = 8.5884 Norwegian crowns)

Graphic: Sinking feeling https://ift.tt/3lpjM9i

(Reporting by Abhinav Ramnarayan and Oliver Hirt. Editing by Jane Merriman)

Source Link Analysis-Europe’s record IPO year has a sting in its tail

David Barret
David Barret

Related posts:

  1. Exiled Ghani apologizes to Afghan people
  2. WHO’s Tedros wins German backing for second term
  3. Alpha Medical closes $24M Series B round to expand women’s telehealth – without the video calls
  4. Lufthansa gets strong investor backing for 2.1 billion euro cash call

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • New Species Of Early Human Lived Alongside The Oldest Known Homo, We Still Don’t Fully Know What Long COVID Actually Is, And Much More This Week
  • New AI Model May Predict Success Of Future Fusion Experiments, Saving Money And Fuel
  • Orange Crocodiles, New Human Species, And Death By Meteorite
  • The World’s Largest Terrestrial Carnivore Has Clear Fur And Black Skin, But You Wouldn’t Know It
  • Deep-Sea Explorers Found A Sunken Whale Carcass – And Watched A Wild Banquet Unfold
  • Does Jupiter Have A Solid Core, And If So, How Big Is It?
  • Trump’s Executive Order To Slash Environmental Regulations For Space Launches: We Look At The Risks And Realities
  • An Underwater Volcano Off The US Coast Is Set To Erupt in 2025, Raising Excitement And Worry
  • Hate Doubling Back On Yourself? Psychologists Have Described A New Bias That May Explain Why
  • A New View Of The “Cosmic Grapes” Is Challenging Our Theories Of How Galaxies Form
  • Ann Hodges: The Only Confirmed Person To Be Hit By A Meteorite And Live
  • Massive Offshore Canyon Expedition Discovers Barbie Lobsters, Sea Pigs, And 40 Potential New Species
  • The Pleiades Will Dance With The Moon This Weekend
  • Tennis Player Gets Public Confused With Autograph About The Fermi Paradox
  • Woman Unearths 2.3 Carat Diamond For Her Future Engagement Ring In State Park
  • RFK Jr Wanted A Journal To Retract This Massive Study On Aluminum In Vaccines. It Refused
  • Can You See The Frog In This Photo? Incredible Camouflage Shows Wildlife Survival Strategy
  • Do Crab-Eating Foxes Actually Eat Crabs?
  • Death Valley’s “Racing Rocks” Inspire Experiment To Make Ice Move On Its Own
  • Parasite “Cleanses”: Are We Riddled With Worms Or Is This Just The Latest Bogus Fad?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version